top of page
2026 Termination of Prostate Biopsy 55700 CPT® Code: What You Need to Know
Current Procedural Terminology (CPT®) codes, developed and maintained by the American Medical Association (AMA), are updated annually to...
Sep 23 min read
Focal Therapy Revolution: How Navigo Fusion and SmartBx Are Changing Prostate Cancer Treatment
Focal therapy is a relatively recent addition to physician's toolkits to safely and effectively treat prostate cancer. It offers patients...
May 164 min read
The Value of Bringing Prostate Fusion into the Hospital OR, Surgery Center, Outpatient Clinic
For hospitals, the Navigo 4D Fusion Navigation System is not just important for providing access to a gold standard of care — it's a...
May 124 min read
Beyond the Biopsy: UC-Care's Comprehensive Approach to Prostate Cancer Treatment Planning and Management
The MRI fusion-guided biopsy of the future takes biopsies from collection, to analysis, to treatment planning, and provides numerous...
Apr 294 min read
Navigating the Financial Landscape: How Navigo 4D Boosts Urology Practice Revenue
For many practices, the Navigo 4D Fusion Navigation System is not just a clinical innovation—it's a financial growth strategy. With low...
Mar 113 min read
Bringing MRI-Guided Biopsies In-House: How Everyone Wins
MRI-guided fusion biopsies have transformed prostate cancer detection, offering superior accuracy compared to traditional non-targeted...
Dec 30, 20244 min read
How MRI-Targeted Prostate Fusion Biopsies Improve Reimbursements and Streamline Efficiency
A New Era in Prostate Cancer Diagnosis The ultrasound (US)-guided prostate biopsy – also called a “systematic” biopsy – was the...
Dec 4, 20243 min read
Enhancing Pathology Precision: The Importance of Preserving Specimen Integrity from Needle to Slide
Approximately 1 million prostate cancer biopsies are performed each year in the U.S., but a recent study found that standard US-guided...
Oct 31, 20243 min read
Optimizing the MRI-US Fusion Prostate Biopsy Workflow
Historically, ultrasound (US)-guided biopsies were the standard of care for diagnosing prostate cancer. However, these “blind” biopsies...
Sep 17, 20243 min read
Untargeted Prostate Biopsies: Where Do They Fall Short?
Prostate cancer is the leading cancer affecting men, comprising nearly 15% of all new cancer cases each year. 1 However, despite the...
Aug 16, 20243 min read
The Case for In-Office Fusion Prostate Biopsies
Historically, ultrasound (US)-guided biopsies defined the standard of care for prostate cancer diagnostics. Recent and emerging evidence,...
Jul 25, 20243 min read
bottom of page